Table 1.
Immunization | Time After Challenge, d | Viral Titer, Mean (SD) log10 PFUs/g |
|
---|---|---|---|
Nasal Turbinates | Lungs | ||
Medium | 3 | 7.4 (0.2) | 8.5 (0.4) |
6 | 7.0, NA, NAb | 7.1, NA, NAb | |
PR8/PB2-GFP virus | 3 | 6.9 (0.2) | 7.8 (0.9) |
6 | 5.8 (0.3) | 6.4, 4.5 | |
PR8/PB2-PspA virus | 3 | 7.8, 7.9 | 8.5 |
6 | NDc | ND |
Abbreviations: GFP, green fluorescent protein; NA, not applicable; ND, not detected; PFUs, plaque-forming units; PspA, pneumococcal surface protein A; SD, standard deviation.
a Mice were intranasally immunized with the indicated agents (50 µL) 3 times at 2-week intervals. Two weeks after the final vaccination, the immunized mice were challenged with 10-fold 50% mouse lethal dose of PR8 virus (50 µL). Nasal turbinates and lungs were harvested from the challenged mice (n = 3) on days 3 and 6 after challenge and subjected to virus titration by plaque assays in AX4/PB2 cells. When virus was not recovered from all 3 mice, individual titers are provided.
b NA because the mice died.
c The detection limit was 1.5 log10 PFUs/g.